Nebulised frusemide to imporve the sensation and unpleasant feeling of dyspnoea in patients with advanced diseases and breathlessness refractory to optimal standard management

Authors
Category Primary study
Registry of TrialsAustralian New Zealand Clinical Trials Register
Year 2012
This article has no abstract
Epistemonikos ID: 6d2a2b2f9672a12bfc6298e03a0411b531608241
First added on: Feb 22, 2025